Journal of Nuclear Medicine March 2025, jnumed.124.268959; DOI: https://doi.org/10.2967/jnumed.124.268959 ...

Journal of Nuclear Medicine April 2025, jnumed.124.268519; DOI: https://doi.org/10.2967/jnumed.124.268519 ...

Journal of Nuclear Medicine April 2025, jnumed.124.269290; DOI: https://doi.org/10.2967/jnumed.124.269290 ...

Journal of Nuclear Medicine April 2025, jnumed.124.268880; DOI: https://doi.org/10.2967/jnumed.124.268880 ...

Journal of Nuclear Medicine April 2025, jnumed.124.269361; DOI: https://doi.org/10.2967/jnumed.124.269361 ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Journal of Nuclear Medicine March 2025, jnumed.125.269548; DOI: https://doi.org/10.2967/jnumed.125.269548 ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

A total of 198 consecutive patients with a clinically stable heart, angiographically proven chronic coronary artery disease, a left ventricular ejection fraction (LVEF) ≤ 40%, and heart failure ...

Until the Surgical Treatment for Ischemic Heart Failure (STICH) viability study (10), only 1 randomized study (11) investigated whether evaluation of viability using PET to select patients with LV ...

Learning Objectives 1. Become familiar with QC tests specified by nuclear medicine (NM) accreditation programs. 2. Be able to evaluate test results to ensure performance specifications are maintained.

Objectives A diffuse or focal bone marrow (BM) FDG uptake usually reflects hyperplastic BM or pathologic process such as involvement of malignancy or hematopoietic disease. We have sometimes ...